학술논문

First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Document Type
Article
Source
In: Oncologist. (Oncologist, April 2024, 29(4):e514-e525)
Subject
Language
English
ISSN
1549490X
10837159